Latest Adult stem cell Stories

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013 JUPITER, Fla., May 21, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference. The conference will be held on Thursday, May 30, 2013 at the Grand Hyatt Hotel, located at...

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert L. Wilensky, MD, Professor of Medicine and Director of Interventional Cardiology Research at the University of Pennsylvania has agreed to join the Scientific and Medical Advisory Board for Stemedica’s Cardiology Division. San Diego, CA (PRWEB) May 20, 2013 Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing,...

SEOUL, South Korea, May 20, 2013 /PRNewswire/ -- RNL BIO Co. Ltd., a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, announces the availability of adult stem cell banking in the United States beginning on June 20, 2013. RNL BIO previously offered these services through another company, but will now provide the latest, safest technologies directly. As the sole global...

Device Plays Integral Role in Delivering Stem Cells for its Proprietary Bulging/Herniated Disc Therapy JUPITER, Fla., May 20, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity"). Dexterity is a product design and bioengineering firm that will provide...

Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according to a new study released today in STEM CELLS Translational Medicine. Durham, NC (PRWEB) May 15, 2013 Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according...

WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Scientists in Oregon announced today that they had created cloned human embryos, and then destroyed the embryos to extract embryonic stem cells. The cloning technique is essentially the same one used to create Dolly the cloned sheep, with some modifications to make cloning work using human eggs and human cells. This is the first claim of growing human embryonic stem cells from cloned human embryos since the fraudulent claims in...

SAN RAMON, Calif., May 15, 2013 /PRNewswire-USNewswire/ -- The Center for Bioethics and Culture strongly decries the practice of deriving human embryonic stem cells through cloning because it exploits women for their eggs, it commodifies human life, and it is unnecessary. In the June 6, 2013, issue of the scientific journal Cell, researchers announce that they have successfully derived human embryonic stem cells through somatic cell nuclear transfer (SCNT) cloning. The authors of the...

Cord Blood Educational Meetings are Launched by GeneCell International’s Physician Relation's Manager in order to increase awareness in South Florida's Expecting Parents Miami, Florida (PRWEB) May 08, 2013 Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager, announced today her contribution in educating South Florida’s expecting parents to advance the awareness in the community. Expecting parents in Miami are encourage attend these...

Brett Smith for redOrbit.com – Your Universe Online When geneticists at the University of Minnesota began work on what they thought was a regulatory gene, they probably had no idea their work would redefine the tiny snippet of genetic material as a key player in stem cell differentiation. According to the team’s report in the journal Cell Stem Cell, the gene Mesp1 is responsible for differentiation of heart, blood and muscle cells from stem cells. “Previous research indicated...

Stemedica Asia PTE, LTD, a wholly owned subsidiary of Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors, announced that the Company has entered into a definitive licensing agreement with the Stem Cell and Cancer Institute, a division of PT Kalbe Farma (Kalbe). San Diego, CA (PRWEB) April 25, 2013 Stemedica Asia PTE, LTD, a wholly owned subsidiary of Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic...